BNB Plus Corp. filings document a Nasdaq-listed common stock issuer with recurring disclosures on capital structure, stockholder approvals, governance, registration statements, and listing compliance. Form 8-K reports cover matters such as stockholder votes on reverse stock split authority, warrant-related share issuance approvals, Nasdaq minimum-bid-price compliance notices, and board changes.
Proxy materials describe special meeting proposals, voting mechanics, authorized-share considerations, and board authority requested from stockholders. Securities Act registration statement amendments address securities offered from time to time, issuer classification, offering mechanics, and related disclosure controls for the company’s public capital structure.
BNB Plus Corp. disclosed a September 28, 2026 amendment to its registration rights agreement with Comstock Multichain Fund and KGPLA Holdings LLC. It replaced a fixed registration-filing requirement with a demand right: holders of at least 51% in interest of then-outstanding Registrable Securities may demand resale registration, with no more than two demands and filing due on or before the 45th calendar day after receipt. Signatories waived prior performance failures and related claims. BNB Plus also corrected its cover-page market reference from The Nasdaq Stock Market to OTCQB Venture Market.
BNB Plus Corp. announced that it will transition from a digital asset treasury strategy focused exclusively on the BNB Chain ecosystem to an operating company focused on infrastructure for institutions and enterprises using blockchain, agentic AI and other open network technologies. It expects to remain active in the BNB Chain ecosystem while redirecting its focus toward network deployment, integration and related infrastructure.
The company is evaluating an expansion of its relationship with GlobalStake Infrastructure, which has led its strategic review. It also intends to evaluate options to strengthen subsidiary LineaRx, Inc.’s positioning in genetic medicines, with the objective of realizing value for stockholders. LineaRx’s enzymatic DNA platform produces DNA used in mRNA and other genetic medicines.
BNB Plus Corp. amended its Registration Rights Agreement, replacing the prior registration-filing requirement with an obligation triggered by a demand from holders of at least 51% in interest of then-outstanding Registrable Securities. A demand may cover the resale of any or all Registrable Securities.
Holders may make no more than two demands, and BNB Plus must file a registration statement on or before the 45th calendar day following receipt of a demand. Each amendment signatory also waived failures to perform under the agreement occurring on or before September 28, 2026, and released BNB Plus from claims relating to those failures.
BNB PLUS CORP. (BNBX) reported that director Shorten Richard Lee Jr. received a grant of stock options covering 100,000 shares of common stock on September 14, 2026. The options have an exercise price of $0.15 per share, vest in equal monthly installments over six months, and expire on September 14, 2036.
The options are held directly by the reporting person, who may at his discretion transfer some or all of the economic interest to affiliated funds. No Rule 10b5-1 trading plan is reported for this award.
BNB PLUS CORP. (BNBX) reported that director Todd Larsen received a grant of 100,000 stock options on September 14, 2026. The options have an exercise price of $0.15 per share, expire on September 14, 2036, and vest in equal monthly installments over six months.
BNB PLUS CORP. (BNBX) director Lee Lok received a grant of stock options for 100,000 shares of common stock on September 14, 2026. The options have an exercise price of $0.15 per share, expire on September 14, 2036, and vest in equal monthly installments over six months, commencing one month from the grant date. No Rule 10b5-1 trading plan is reported for this award.
BNB PLUS CORP. (BNBX) discloses that Lee Lok has filed an initial statement of beneficial ownership on Form 3 as a director of the company. The filing reports no transactions, no derivative positions, and does not list any specific share holdings at this time.
BNB PLUS CORP. (BNBX) director Shorten Richard Lee Jr. has filed an initial ownership report showing indirect positions in several preferred stock and warrant classes convertible into common stock. These securities are held by Comstock MultiChain Fund, L.P., for which affiliated entities advised and majority-owned by him act as investment advisor and general partner, and he disclaims beneficial ownership beyond any pecuniary interest.
BNB PLUS CORP. (BNBX) reported that Todd Larsen is a director and has filed an initial Form 3 statement of beneficial ownership. The filing lists no equity transactions and no holdings or derivative positions for him at the time of this report.